Rosebud Biosciences accelerates drug development by screening drugs against organoids (micro-organs) that have the same gene mutations as the patients. We partner with therapeutics companies to screen their drugs, and we perform our own drug discovery for rare diseases that have no existing treatments. Our organoids are also fetal-like and enable discovery of novel drug targets for pediatric diseases. This technology was validated at Stanford, published in a prestigious journal, and has already led to the discovery of a drug target in a pediatric heart disease that could not have been found using traditional disease models.
Rosebud Biosciences is an early-stage startup dedicated to developing therapies for rare genetic diseases in children. By modeling human development with organoids that replicate the child's genetic mutations, we accelerate the search for effective cures.
Rosebud Biosciences offers customized pricing based on the specific needs of your research or drug development project. Contact us for detailed pricing information tailored to your requirements.
Rosebud Biosciences is actively seeking talented individuals to join our team. Explore job opportunities and become a part of our mission to find cures for rare genetic diseases.
Contact us to learn more about how Rosebud Biosciences can support your drug development efforts. Our team of experts is ready to assist you in achieving your research goals.
Make undruggable targets a thing of the past
Match with like-minded professionals for 1:1 conversations
Go from Slack Chaos to Clarity in Minutes
Personalize 1000s of landing pages in under 30 mins
The first LLM for document parsing with accuracy and speed
AI Assistants for SaaS professionals
AI-powered phone call app with live translation
Delightful AI-powered interactive demos—now loginless
AI Motion Graphics Copilot
Pop confetti to get rid of stress & anxiety, 100% AI-free
Smooth payments for SaaS